These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Beneficial effect of granulocyte-colony stimulating factor in scleromyxoedema associated with severe idiopathic neutropenia. Cohen AM; Hodak E; David M; Mittelman M; Gal R; Stern R Br J Dermatol; 1996 Oct; 135(4):626-9. PubMed ID: 8915161 [TBL] [Abstract][Full Text] [Related]
4. Intravenous immunoglobulins control scleromyxoedema. Righi A; Schiavon F; Jablonska S; Doria A; Blasczyk M; Rondinone R; Todesco S; Matucci Cerinic M Ann Rheum Dis; 2002 Jan; 61(1):59-61. PubMed ID: 11779761 [TBL] [Abstract][Full Text] [Related]
6. Tumorous variant of scleromyxedema. Successful therapy with intravenous immunoglobulins. Wojas-Pelc A; Błaszczyk M; Glińska M; Jabłońska S J Eur Acad Dermatol Venereol; 2005 Jul; 19(4):462-5. PubMed ID: 15987294 [TBL] [Abstract][Full Text] [Related]
7. Arndt-Gottron scleromyxoedema: successful therapy with intravenous immunoglobulins. Gholam P; Hartmann M; Enk A Br J Dermatol; 2007 Nov; 157(5):1058-60. PubMed ID: 17854360 [No Abstract] [Full Text] [Related]
8. Koebner phenomenon due to scratch test in scleromyxoedema. Durani BK; Kurzen H; Hartschuh W; Naeher H Br J Dermatol; 2001 Aug; 145(2):306-8. PubMed ID: 11531798 [TBL] [Abstract][Full Text] [Related]
9. Scleromyxoedema: treatment of cutaneous and systemic manifestations with high-dose intravenous immunoglobulin. Kulczycki A; Nelson M; Eisen A; Heffernan M Br J Dermatol; 2003 Dec; 149(6):1276-81. PubMed ID: 14674909 [TBL] [Abstract][Full Text] [Related]
10. Scleroderma-like manifestation in a patient with primary systemic amyloidosis: response to high-dose intravenous immunoglobulin and plasma exchange. Cho SB; Park JS; Kim HO; Chung KY Yonsei Med J; 2006 Oct; 47(5):737-40. PubMed ID: 17066519 [TBL] [Abstract][Full Text] [Related]
11. High-dose intravenous immunoglobulin infusion as treatment for diffuse scleroderma. Ihn H; Mimura Y; Yazawa N; Jinnin M; Asano Y; Yamane K; Tamaki K Br J Dermatol; 2007 May; 156(5):1058-60. PubMed ID: 17381465 [No Abstract] [Full Text] [Related]
12. Case 5: extensive skin eruption causing skin to become tight, sore, and itchy. Diagnosis: scleromyxoedema. Karim A; Black MM; Lawlor F Clin Exp Dermatol; 2003 May; 28(3):343-4. PubMed ID: 12780738 [No Abstract] [Full Text] [Related]
13. Scleromyxoedema: clinical follow-up after successful treatment with high-dose immunoglobulins reveals different long-term outcomes. Bidier M; Zschoche C; Gholam P; Enk AH; Hadaschik EN Acta Derm Venereol; 2012 Jul; 92(4):408-9. PubMed ID: 22278389 [No Abstract] [Full Text] [Related]
14. Elephantiasic pretibial myxoedema with upper-limb involvement, treated with low-dose intravenous immunoglobulins. Dhaille F; Dadban A; Meziane L; Fessier C; Colta L; Lok C; Chaby G Clin Exp Dermatol; 2012 Apr; 37(3):307-8. PubMed ID: 22007759 [No Abstract] [Full Text] [Related]
15. Intravenous immunoglobulin treatment recovers the down-regulated levels of Th1 cytokines in the sera and skin of scleroderma patients. Kudo H; Jinnin M; Yamane K; Makino T; Kajihara I; Makino K; Honda N; Nakayama W; Fukushima S; Ihn H J Dermatol Sci; 2013 Jan; 69(1):77-80. PubMed ID: 23102713 [No Abstract] [Full Text] [Related]